Biological E’s novel polio vaccine receives WHO’s pre-qualification status nOPV2 is a next-generation oral vaccine developed to combat cVDPV2 outbreaks
CORBEVAX gets DCGI nod as a heterologous COVID-19 booster dose People who are 18 years and above and have already taken two doses of either covishield or covaxin can now receive a dose of…
Biological E. reduces corbevax price to Rs 250 a dose The move comes a few weeks after receiving the EUA for children between the ages of 5 and 12
Corbevax by Biological E gets DCGI approval CORBEVAX is India’s 1st indigenously developed protein sub-unit COVID-19 vaccine
Centre says over two billion COVID-19 vaccine doses to be available between August and December 2021 Dr V K Paul, member (health), NITI Aayog said that by the first quarter of the next year, the number is likely to be three billion
PM to interact with Gennova Biopharma, Biological E, DRL teams today The Prime Minister Shri Narendra Modi will continue his interactions with COVID-19 vaccine manufacturers this week too. In a…
Indian pharma industry can produce COVID-19 vaccines for entire world: Bill Gates India has a lot of capacity there -- with the drug and vaccine companies that are huge suppliers to the entire world. You know,…